Therapeutic agent for arteriosclerosis or arteriosclerotic disease, and diagnostic agent for arteriosclerosis or arteriosclerotic disease
AssigneesMasaaki Miyata, Taku Nagai, Takami Matsuyama
InventorsChuwa Tei, Masaaki Miyata, Yuko Furusyo, Takami Matsuyama, Taku Nagai
Life of this patent
Estimating the term…
Abstract
It is intended to ameliorate arteriosclerosis or arteriosclerotic disease through a pharmacological mechanism that reduces the size of the arteriosclerotic lesion. The agent of the present invention comprises a complex comprising an antibody binding to folate receptor β (FRβ) and a cytotoxin or a cytotoxic agent conjugated with the antibody, or the antibody as an active ingredient.
Claims16
-15. (canceled)
A therapeutic agent for arteriosclerosis or arteriosclerotic disease, comprising a complex comprising an antibody specifically binding to folate receptor β (FRβ) and a cytotoxin or a cytotoxic agent conjugated with the antibody, or the antibody as an active ingredient.
A diagnostic agent for arteriosclerosis or arteriosclerotic disease, comprising an antibody specifically binding to folate receptor β (FRβ) as an active ingredient.
Dependencies are inferred from the claim text.